Surgery, Science, and Inclusion - Summary - MDSpire

Surgery, Science, and Inclusion

Upfront: Monthly reflection by Editor in Chief Diana V. Do, MD.

  • By

  • Diana V. Do, MD

  • July 14, 2025

  • 3 min

Share

Objective:

To discuss the importance of inclusion in clinical research and provide specific updates on complex surgical procedures and treatment advancements in the retina community.

Approach:
    Key Findings:
    • Inclusion in clinical trials is crucial for reflecting real-world patient demographics and improving treatment outcomes.
    • Surgical techniques for intraocular foreign body removal vary and require specific expertise, which can influence surgical success.
    • Scleral buckling shows promising outcomes for retinal detachment compared to vitrectomy, particularly in certain patient populations.
    • Proper coding and documentation are essential for successful retina surgery management, impacting reimbursement and compliance.
    • Updates in local steroid treatments for uveitis may influence future management strategies, potentially improving patient care.
    Interpretation:

    The articles emphasize the need for inclusivity in clinical research and provide valuable insights into complex surgical techniques and treatment updates in the retina field.

    Limitations:
    • The article does not provide specific data or statistics to support claims about inclusion rates, which could strengthen the argument.
    • Surgical techniques discussed may not be universally applicable to all cases, particularly in patients with unique anatomical considerations.
    Conclusion:

    The issue highlights the importance of inclusivity in research and offers practical insights into surgical practices and treatment advancements in the retina community.

Original Source(s)

Surgery, Science, and Inclusion

  • by Diana V. Do, MD

  • July 14, 2025

Related Content

Treatment Strategies in Endogenous Fungal Endophthalmitis

Management of endogenous fungal endophthalmitis is complex, with wide variation in treatment strategies. Systemic markers of disease appear to influence the choice of initial therapy more than ocular findings. Although no definitive evidence favors IV over oral systemic therapy, a comprehensive, multidisciplinary approach that considers ocular involvement is essential to optimize patient outcomes in EFE.

A Novel Technique for Uveitis

Dr. David Chin Yee describes the benefits of delivering XIPERE directly into the suprachoroidal space

Smoking Doubles Risk of Vision Loss

New research indicates smoking doubles the risk of multiple sight-threatening conditions

  • May 15, 2026

  • 3 min